Literature DB >> 21747218

The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations.

L Tian1, M Fu.   

Abstract

The HDL fraction in human plasma is heterogeneous in terms of size, shape, composition, and surface charge. The HDL subclasses contents were quantified by 2-dimensional non-denaturing gel electrophoresis, immunoblotting, and image analysis. This research review systematically analyzed the relationship between the contents of HDL subclasses and the concentrations and ratios of the 5 major plasma apolipoproteins (apo). As the concentration of apoA-I increases, the contents of all HDL subclasses increase significantly. The most significant association was observed between large-sized HDL2b contents and apoA-I. ApoA-II played a dual function in the contents of HDL subclasses, and both small-sized HDL3b and HDL3a and large-sized HDL2b tended to increase with apoA-II concentration. An increase in the concentrations of apoC-II, C-III, and B-100 resulted in higher levels of small-sized HDL particles and lower levels of large-sized HDL particles. Plasma apoB- 100, apoC-II, and apoC-III appear to play a coordinated role in assembly of HDL particles and the determination of their contents. Higher concentrations of apoA-I could inhibit the reduction in content of large-sized HDL2b effected by apoB-100, C-II, and C-III. The preβ1-HDL contents increased significantly and those of HDL2b declined progressively with an increased apoB-100/apoA-I or a decreased apoC-III/apoC-II ratio. In summary, each apo has distinct but interrelated roles in HDL particle generation and metabolism. ApoA-I and apoC-II concentrations are independent determinants of HDL subtypes in circulation and apoA-I levels might be a more powerful factor to influence HDL subclasses distribution. Moreover, apoB- 100/apoA-I ratio could reliably and sensitively reflect the HDL subclass profile.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21747218     DOI: 10.1007/BF03346714

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  121 in total

1.  Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis.

Authors:  P T Williams; R M Krauss; A V Nichols; K M Vranizan; P D Wood
Journal:  J Lipid Res       Date:  1990-06       Impact factor: 5.922

Review 2.  Apolipoprotein A-I: structure-function relationships.

Authors:  P G Frank; Y L Marcel
Journal:  J Lipid Res       Date:  2000-06       Impact factor: 5.922

Review 3.  Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.

Authors:  J C Fruchart; G Ailhaud
Journal:  Clin Chem       Date:  1992-06       Impact factor: 8.327

4.  Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.

Authors:  J E Buring; G T O'Connor; S Z Goldhaber; B Rosner; P N Herbert; C B Blum; J L Breslow; C H Hennekens
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

5.  Plasma apoproteins and the severity of coronary artery disease.

Authors:  S P Sedlis; K B Schechtman; P A Ludbrook; B E Sobel; G Schonfeld
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

6.  Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation.

Authors:  D W Borhani; D P Rogers; J A Engler; C G Brouillette
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

7.  Distribution of high-density lipoprotein 2 and 3 constituents during in vitro phospholipid hydrolysis.

Authors:  B P Perret; F Chollet; S Durand; G Simard; H Chap; L Douste-Blazy
Journal:  Eur J Biochem       Date:  1987-01-15

8.  High-density lipoprotein reduces the human monocyte inflammatory response.

Authors:  Andrew J Murphy; Kevin J Woollard; Anh Hoang; Nigora Mukhamedova; Roslynn A Stirzaker; Sally P A McCormick; Alan T Remaley; Dmitri Sviridov; Jaye Chin-Dusting
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

9.  The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.

Authors:  S S Soedamah-Muthu; H M Colhoun; M J Thomason; D J Betteridge; P N Durrington; G A Hitman; J H Fuller; K Julier; M I Mackness; H A W Neil
Journal:  Atherosclerosis       Date:  2003-04       Impact factor: 5.162

10.  Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.

Authors:  C C Hedrick; L W Castellani; C H Warden; D L Puppione; A J Lusis
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

View more
  3 in total

1.  Relationship of Apolipoproteins with Subclinical Cardiovascular Risk in Youth.

Authors:  Madeline A Czeck; Elise F Northrop; Nicholas G Evanoff; Donald R Dengel; Kyle D Rudser; Aaron S Kelly; Justin R Ryder
Journal:  J Pediatr       Date:  2020-08-11       Impact factor: 4.406

2.  High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species.

Authors:  Jianfeng Xu; Juying Qian; Xinxing Xie; Li Lin; Yunzeng Zou; Mingqiang Fu; Zheyong Huang; Guoping Zhang; Yangang Su; Junbo Ge
Journal:  Int J Mol Sci       Date:  2012-12-13       Impact factor: 5.923

3.  Assessment by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry of the Effects of Preanalytical Variables on Serum Peptidome Profiles Following Long-Term Sample Storage.

Authors:  Sachio Tsuchida; Mamoru Satoh; Hiroshi Umemura; Kazuyuki Sogawa; Masaki Takiwaki; Takayuki Ishige; Yui Miyabayashi; Yuuya Iwasawa; Sohei Kobayashi; Minako Beppu; Motoi Nishimura; Yoshio Kodera; Kazuyuki Matsushita; Fumio Nomura
Journal:  Proteomics Clin Appl       Date:  2018-03-02       Impact factor: 3.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.